STOCK TITAN

Zynex Sets Second Quarter 2025 Earnings Call

Zynex (NASDAQ: ZYXI), a medical technology company focused on non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has scheduled its Q2 2025 earnings conference call for July 31, 2025, at 4:15 PM ET.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Zynex (NASDAQ: ZYXI), a medical technology company focused on non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has scheduled its Q2 2025 earnings conference call for July 31, 2025, at 4:15 PM ET.

The company will release its financial results for the quarter ended June 30, 2025, before the call. Management will host the call followed by a Q&A session. Participants can join via phone using the U.S. & Canada dial-in (800-836-8184) or international number (646-357-8785), or through the webcast available on the company's investor relations website.

Loading...
Loading translation...
Argus Session date unavailable
+4.27% session move Open Argus
Details

News Market Reaction – ZYXI

The recorded move for ZYXI in the trading session of this news was +4.27%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

ENGLEWOOD, Colo., July 22, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 31, 2025 at 4:15 PM Eastern Time to discuss its financial results for the second quarter ended June 30, 2025.  Financial results will be issued in a press release prior to the call.

Zynex management will host the conference call, followed by a question and answer session.

Date: Thursday, July 31, 2025
Time: 4:15 PM Eastern Time (2:15 PM Mountain Time)
U.S. & Canada dial-in number: 800-836-8184
International number: 646-357-8785
Webcast: Q2-2025 Webcast Link

The Company will also provide a link at https://zynexmed.investorroom.com/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.

About Zynex, Inc.

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Dan Moorhead, CFO
ir@zynex.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-sets-second-quarter-2025-earnings-call-302510532.html

SOURCE Zynex, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Zynex (ZYXI) reporting Q2 2025 earnings?

Zynex will report Q2 2025 earnings on Thursday, July 31, 2025 at 4:15 PM Eastern Time. Financial results will be released in a press release before the call.

How can investors join the Zynex Q2 2025 earnings call?

Investors can join via phone (U.S. & Canada: 800-836-8184, International: 646-357-8785) or through the webcast available at the company's investor relations website.

What period will Zynex's Q2 2025 earnings cover?

The earnings report will cover Zynex's financial results for the second quarter ended June 30, 2025.

What does Zynex (ZYXI) company do?

Zynex is a medical technology company that manufactures and sells non-invasive medical devices for pain management, rehabilitation, and patient monitoring.

Keep reading